Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Locations section is expanded to include multiple Chinese sites (Beijing Municipality, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Ningxia, Shanxi, Sichuan, Tianjin Municipality, Zhejiang). Individual province location subsections were removed or reorganized, consolidating site information under the new Locations heading.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check51 days agoChange DetectedThe funding/operating-status notice banner was removed. The study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check65 days agoChange DetectedNo additions or deletions were detected on the page. The content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check94 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference5%

- Check101 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.